Insider · CIK 0001718019

Notman Donald

Reports to the SEC for 1 company · BEDFORD, MA

sec.gov

Transactions

Companies

Filings

CIK

0001718019

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-31	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Operating Officer	SSale	−1,099 sh	$10.24	−$11.3K	366,529
2026-02-12	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Operating Officer	SSale	−11.4K sh	$9.04	−$103K	366,356
2026-02-04	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Operating Officer	SSale	−6,035 sh	$8.54	−$51.5K	377,802
2026-02-02	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Operating Officer	SSale	−5,455 sh	$9.14	−$49.9K	383,837
2026-01-02	OCULOCULAR THERAPEUTIX, INCA Award	Chief Operating Officer	AAward	+79.1K sh	—	—	389,292
2026-01-02	OCULOCULAR THERAPEUTIX, INC · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+241K sh	—	—	240,932
2025-09-02	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Operating Officer	SSale	−1,066 sh	$12.43	−$13.3K	308,807
2025-02-11	OCULOCULAR THERAPEUTIX, INCA Award	Chief Operating Officer	AAward	+115K sh	—	—	308,444
2025-02-11	OCULOCULAR THERAPEUTIX, INC · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+344K sh	—	—	344,115
2025-02-04	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Operating Officer	SSale	−11.1K sh	$7.81	−$86.8K	193,444
2025-01-31	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Operating Officer	SSale	−6,301 sh	$7.84	−$49.4K	204,563
2024-08-29	OCULOCULAR THERAPEUTIX, INCA Award	Chief Operating Officer	AAward	+11K sh	—	—	208,988
2024-08-29	OCULOCULAR THERAPEUTIX, INC · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+33.6K sh	—	—	33,602
2024-02-05	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Operating Officer	SSale	+6,212 sh	$4.86	+$30.2K	195,356
2024-02-03	OCULOCULAR THERAPEUTIX, INCA Award	Chief Operating Officer	AAward	+61.6K sh	—	—	201,568
2024-02-03	OCULOCULAR THERAPEUTIX, INC · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+185K sh	—	—	185,000
2024-01-31	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Operating Officer	SSale	−6,433 sh	$4.95	−$31.8K	139,932
2023-02-06	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Operating Officer	SSale	−6,476 sh	$4.24	−$27.5K	139,387
2023-01-30	OCULOCULAR THERAPEUTIX, INCA Award	Chief Operating Officer	AAward	+55.6K sh	—	—	145,863
2023-01-30	OCULOCULAR THERAPEUTIX, INC · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+167K sh	—	—	166,667
2022-02-03	OCULOCULAR THERAPEUTIX, INCA Award	Chief Operating Officer	AAward	+55.6K sh	—	—	81,632
2022-02-03	OCULOCULAR THERAPEUTIX, INC · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+167K sh	—	—	166,667
2021-02-17	OCULOCULAR THERAPEUTIX, INC · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+190K sh	—	—	190,000
2020-01-30	OCULOCULAR THERAPEUTIX, INC · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+215K sh	—	—	215,000
2019-06-14	OCULOCULAR THERAPEUTIX, INCP Purchase	Chief Operating Officer	PPurchase	+2,500 sh	$4.33	+$10.8K	24,049
2019-01-02	OCULOCULAR THERAPEUTIX, INC · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+150K sh	—	—	150,000
2018-08-14	OCULOCULAR THERAPEUTIX, INCP Purchase	Chief Operating Officer	PPurchase	+12.5K sh	$6.29	+$78.6K	17,300
2018-01-31	OCULOCULAR THERAPEUTIX, INC · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+83.5K sh	—	—	83,500
2017-12-07	OCULOCULAR THERAPEUTIX, INCP Purchase	Chief Operating Officer	PPurchase	+4,800 sh	$4.00	+$19.2K	4,800
2017-10-02	OCULOCULAR THERAPEUTIX, INC · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+125K sh	—	—	125,000

Recent filings

Accepted (ET)
Sep 24
Notman Donald0001104659-26-104727
SEC(opens sec.gov)
Feb 174
Notman Donald0001104659-26-016668
SEC(opens sec.gov)
Feb 44
Notman Donald0001104659-26-010462
SEC(opens sec.gov)
Jan 64
Notman Donald0001104659-26-001282
SEC(opens sec.gov)
Sep 44
Notman Donald0001104659-25-087498
SEC(opens sec.gov)
Feb 134
Notman Donald0001104659-25-013154
SEC(opens sec.gov)
Feb 44
Notman Donald0001104659-25-009254
SEC(opens sec.gov)
Sep 34
Notman Donald0001104659-24-096367
SEC(opens sec.gov)
Feb 64
Notman Donald0001104659-24-011196
SEC(opens sec.gov)
Feb 24
Notman Donald0001104659-24-010238
SEC(opens sec.gov)
Feb 84
Notman Donald0001104659-23-014684
SEC(opens sec.gov)
Feb 14
Notman Donald0001104659-23-009412
SEC(opens sec.gov)

Companies

OCULAR THERAPEUTIX, INCChief Operating OfficerOCUL

Address

C/O OCULAR THERAPEUTIX, INC. 14 CROSBY DRIVE, 3RD FLOOR

BEDFORD, MA, 01730